The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 4 drug alert for all batches of Marcain Polyamp Steripack 0.5% (bupivacaine hydrochloride) manufactured by AstraZeneca UK Ltd released to the UK market since December 2012 (EL(15)A/09).
This is because of an error on carton and ampoule label about administration. This presentation cannot be administered by intra-articular administration.
To ensure continuity of supply, distribution of affected stock will continue whilst the error is being corrected. Corrected stock is expected to be available for distribution by the end of January 2016.
Further details of the problem are available on the MHRA website.